Lyle Murray

Lyle Murray

Auto-generated profile, based on publicly available information

Lyle Murray

University of the Witwatersrand

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 May 2024 in Circulation Research
Verified
Journal Article
Open access
KMKeir McCutcheon
Keir McCutcheon
UNUnati Nqebelele
Unati Nqebelele
LMLyle Murray
Lyle Murray
TTTeressa Sumy Thomas
Teressa Sumy Thomas
DMDineo Mpanya
Dineo Mpanya
Nqoba TsabedzeNqoba Tsabedze
Nqoba Tsabedze
Contemporary World Health Organization data indicates that ≈39 million people are living with the human immunodeficiency virus. Of these, 24 million have been reported to have successfully accessed combination antiretroviral therapy. In 1996, the World Health Organization endorsed the widespread use of combination antiretroviral therapy, transforming human immunodeficiency virus infection from being a life-threatening disease to a chronic illness characterized by multiple comorbidities. The increased access to combination antiretroviral therapy has translated to people living with human immunodeficiency virus (PLWH) no longer having a reduced life expectancy. Although aging as a biological process increases exposure to oxidative stress and subsequent systemic inflammation, this effect is likely enhanced in PLWH as they age. This narrative review engages the intricate interplay between human immunodeficiency virus associated chronic inflammation, combination antiretroviral therapy, and cardiac and renal comorbidities development in aging PLWH. We examine the evolving demographic profile of PLWH, emphasizing the increasing prevalence of aging individuals within this population. A central focus of the review discusses the pathophysiological mechanisms that underpin the heightened susceptibility of PLWH to renal and cardiac diseases as they age.

1 August 2021 in Journal of Infection
Verified
Journal Article
Closed access
JVJacqui Venturas
Jacqui Venturas
JZJarrod Zamparini
Jarrod Zamparini
ESErica Shaddock
Erica Shaddock
SSSarah Stacey
Sarah Stacey
LMLyle Murray
Lyle Murray
CFCharles Feldman
Charles Feldman

1 January 2025 in Wits Journal of Clinical Medicine
Verified
Journal Article
Closed access
LMLyle W Murray
Lyle W Murray
FVFrancois Venter
Francois Venter

11 January 2023 in Southern African Journal of HIV Medicine
Verified
Journal Article
Open access
JBJeffrey Bolon
Jeffrey Bolon
ASAmy Samson
Amy Samson
NINatalie Irwin
Natalie Irwin
LMLyle Murray
Lyle Murray
LMLanganani Mbodi
Langanani Mbodi
JZJarrod Zamparini
Jarrod Zamparini
Background: Cervical cancer is the most common malignancy affecting South African women aged 15–44 years, with a higher prevalence among women living with HIV (WLWH). Despite recommendations for a screening target of 70%, the reported rate of cervical cancer screening in South Africa is 19.3%.Objectives: To investigate the adherence of healthcare workers to cervical cancer screening guidelines in a tertiary-level HIV clinic.Method: A retrospective cross-sectional record audit of women attending the Charlotte Maxeke Johannesburg Academic Hospital HIV Clinic over a 1-month period.Results: Out of 403 WLWH who attended the clinic, 180 (44.7%) were screened for cervical cancer in the 3 years prior to the index consultation. Only 115 (51.6%) of those women with no record of prior screening were subsequently referred for screening. Women who had undergone screening in the previous 3 years were significantly older (47 years vs 44 years, P = 0.046) and had a longer time since diagnosis of their HIV (12 years vs 10 years, P = 0.001) compared to women who had not undergone screening. There was no significant difference in CD4 count or viral suppression between women who had and had not undergone screening.Conclusion: The rate of cervical cancer screening in our institution is below that recommended by the World Health Organization and the South African National Department of Health.

15 March 2023 in IDCases
Verified
Journal Article
Open access
LMLyle Murray
Lyle Murray
MVMichelle Venter
Michelle Venter
MGMichel Le Grange
Michel Le Grange
RMRuchika Meel
Ruchika Meel
Salmonella infections are responsible for a large burden of disease worldwide. Non-typhoidal Salmonella (NTS) species cause a myriad of disease manifestations, particularly amongst severely immunocompromised individuals. We present a rare case of endocarditis caused by the NTS species Salmonella Enteritidis in an individual living with HIV and hepatitis C. In this case, endocarditis was complicated by embolization and acute arterial occlusion of the left arm, as well as mitral valve perforation resulting in cardiac failure. A review of the available literature shows few cases of NTS causing endocarditis in people living with HIV, with the earliest reported case in 1983. Our case demonstrates the potential complications of NTS endocarditis and highlights the importance of evaluating patients with NTS-associated blood stream infection for cardiovascular involvement. Prompt surgical intervention in addition to appropriate antimicrobial therapy is essential to reduce the high morbidity and mortality associated with NTS endocarditis.

6 October 2022 in Global Health, Epidemiology and Genomics
Verified
Journal Article
Open access
PDF file
AMAndrew May
Andrew May
HSHeather Seymour
Heather Seymour
Harriet EtheredgeHarriet Etheredge
Harriet Etheredge
HMHeather Maher
Heather Maher
MNMarta Nunes
Marta Nunes
MRMichèle Ramsay
Michèle Ramsay
Host genetic factors are known to modify the susceptibility, severity, and outcomes of COVID-19 and vary across populations. However, continental Africans are yet to be adequately represented in such studies despite the importance of genetic factors in understanding Africa’s response to the pandemic. We describe the development of a research resource for coronavirus host genomics studies in South Africa known as COVIGen-SA—a multicollaborator strategic partnership designed to provide harmonised demographic, clinical, and genetic information specific to Black South Africans with COVID-19. Over 2,000 participants have been recruited to date. Preliminary results on 1,354 SARS-CoV-2 positive participants from four participating studies showed that 64.7% were female, 333 had severe disease, and 329 were people living with HIV. Through this resource, we aim to provide insights into host genetic factors relevant to African-ancestry populations, using both genome-wide association testing and targeted sequencing of important genomic loci. This project will promote and enhance partnerships, build skills, and develop resources needed to address the COVID-19 burden and associated risk factors in South African communities.